Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Open-market sale Director sold 15,000 shares at an average $27.49 ($412,425)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Other events
  4. 4 Open-market sale Chief Scientific Officer sold 18,416 shares at an average $28.71 ($528,689)
  5. 3 Insider Initial Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 8-K Event Executive or director change · Other events
  8. CT ORDER Other Confidential Order
  9. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at an average $18.98 ($80,644)
  10. 8-K Event Other events
  11. D Other Notice of Sales of Unregistered Securities
  12. 8-K Event Material agreement · Unregistered share sale
  13. 8-K Event Other events
  14. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $27.39 ($310,393)
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Director sold 6,373 shares at $33.50 ($213,508)
  18. 4 Open-market sale Director sold 8,028 shares at $33.91 ($272,225)
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Open-market sale Director sold 116,554 shares at $34.24 ($3,990,378)

Page 40 of 47 · 923 filings